These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9375939

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mibefradil: a new class of calcium-channel antagonists.
    Billups SJ, Carter BL.
    Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN, Markham A.
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [Abstract] [Full Text] [Related]

  • 5. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
    Davies GJ, Tzivoni D, Kobrin I.
    Am J Cardiol; 1997 Aug 21; 80(4B):34C-39C. PubMed ID: 9286852
    [Abstract] [Full Text] [Related]

  • 6. Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
    Massie BM.
    Am J Hypertens; 1998 Apr 21; 11(4 Pt 3):95S-102S. PubMed ID: 9607373
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM, Lacourcière Y, Viskoper R, Woittiez A, Kobrin I.
    Am J Cardiol; 1997 Aug 21; 80(4B):27C-33C. PubMed ID: 9286851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension.
    Oparil S.
    Am J Hypertens; 1998 Apr 21; 11(4 Pt 3):88S-94S. PubMed ID: 9607372
    [Abstract] [Full Text] [Related]

  • 11. Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure.
    Mulder P, Richard V, Compagnon P, Henry JP, Lallemand F, Clozel JP, Koen R, Macé B, Thuillez C.
    J Am Coll Cardiol; 1997 Feb 21; 29(2):416-21. PubMed ID: 9014998
    [Abstract] [Full Text] [Related]

  • 12. Diversity of calcium antagonists.
    Pitt B.
    Clin Ther; 1997 Feb 21; 19 Suppl A():3-17. PubMed ID: 9385501
    [Abstract] [Full Text] [Related]

  • 13. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker.
    Clozel JP, Ertel EA, Ertel SI.
    J Hypertens Suppl; 1997 Dec 21; 15(5):S17-25. PubMed ID: 9481612
    [Abstract] [Full Text] [Related]

  • 14. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G, Lüscher TF.
    Cardiology; 1998 Dec 21; 89 Suppl 1():10-5. PubMed ID: 9570424
    [Abstract] [Full Text] [Related]

  • 15. Potential cardioprotective effect of mibefradil in the long-term treatment of hypertension.
    Waeber B.
    Cardiology; 1998 Dec 21; 89 Suppl 1():16-22. PubMed ID: 9570425
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA, Daniëls MC, Holwerda NJ, Withagen PJ, Schelling A, Cleophas TJ, Hendriks MG.
    Angiology; 1999 Jun 21; 50(6):447-54. PubMed ID: 10378820
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA, Daniëls MC, Holwerda NJ, Withagen PJ, Schelling A, Cleophas TJ, Hendriks MG.
    Br J Clin Pharmacol; 1999 May 21; 47(5):493-8. PubMed ID: 10336572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.